Antisense compounds, compositions and methods are provided for modulating
the expression of TFAP2C. The compositions comprise antisense compounds,
particularly antisense oligonucleotides, targeted to nucleic acids
encoding TFAP2C. Methods of using these compounds for modulation of
TFAP2C expression and for treatment of diseases associated with
expression of TFAP2C are provided.